SPI
16.812,63
PKT
+62,42
PKT
+0,37
%
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 07.09.22 | Zurich Insurance Buy | UBS AG | |
| 07.09.22 | UBS Neutral | UBS AG | |
| 07.09.22 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 07.09.22 | Zurich Insurance Outperform | Credit Suisse Group | |
| 07.09.22 | Zurich Insurance Overweight | JP Morgan Chase & Co. | |
| 07.09.22 | Swiss Re Neutral | JP Morgan Chase & Co. | |
| 06.09.22 | UBS Outperform | RBC Capital Markets | |
| 06.09.22 | UBS Sector Perform | RBC Capital Markets | |
| 06.09.22 | UBS Overweight | JP Morgan Chase & Co. | |
| 06.09.22 | ABB (Asea Brown Boveri) Outperform | Bernstein Research | |
| 05.09.22 | Swiss Re Sector Perform | RBC Capital Markets | |
| 05.09.22 | Nestlé Overweight | JP Morgan Chase & Co. | |
| 05.09.22 | UBS Overweight | JP Morgan Chase & Co. | |
| 04.09.22 | UBS Buy | Jefferies & Company Inc. | |
| 02.09.22 | Swiss Re Equal Weight | Barclays Capital | |
| 02.09.22 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 02.09.22 | DocMorris Buy | Warburg Research | |
| 02.09.22 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 01.09.22 | ABB (Asea Brown Boveri) Buy | UBS AG | |
| 01.09.22 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 01.09.22 | DocMorris Buy | Warburg Research | |
| 01.09.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 31.08.22 | Givaudan Sell | UBS AG | |
| 31.08.22 | DocMorris Buy | Jefferies & Company Inc. | |
| 31.08.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 31.08.22 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 31.08.22 | DocMorris Buy | Jefferies & Company Inc. | |
| 31.08.22 | UBS Hold | Deutsche Bank AG | |
| 30.08.22 | Peach Property Group Kaufen | SRC Research GmbH | |
| 26.08.22 | Richemont Conviction Buy List | Goldman Sachs Group Inc. | |
| 26.08.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 26.08.22 | Swiss Re Equal Weight | Barclays Capital | |
| 25.08.22 | Richemont Overweight | Barclays Capital | |
| 25.08.22 | Richemont Buy | UBS AG | |
| 25.08.22 | Novartis Neutral | UBS AG | |
| 25.08.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 24.08.22 | Richemont Buy | Deutsche Bank AG | |
| 24.08.22 | Swiss Re Sell | Goldman Sachs Group Inc. | |
| 24.08.22 | Richemont Outperform | Bernstein Research | |
| 24.08.22 | Richemont Outperform | RBC Capital Markets |